Cite
HARVARD Citation
Cooper, C. et al. (2014). Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy. Canadian journal of gastroenterology & hepatology. 28 (1), pp. 35-40. [Online].